This observation may be consistent with a lower threshold for proliferation induction for CD8+ tumor-infiltrating lymphocytes (TIL), which may be receiving a concurrent antigen signal, or may signify migration of cells from the periphery into the tumor following therapy. Here, CD8A is linked to neoplasm.